Cooperativity in lipid activation of 3-hydroxybutyrate dehydrogenase: role of lecithin as an essential allosteric activator
- PMID: 2742824
- DOI: 10.1021/bi00433a040
Cooperativity in lipid activation of 3-hydroxybutyrate dehydrogenase: role of lecithin as an essential allosteric activator
Abstract
3-Hydroxybutyrate dehydrogenase (BDH) is a lecithin-requiring mitochondrial enzyme which catalyzes the interconversion of 3-hydroxybutyrate and acetoacetate with NAD(H) as coenzyme. The purified enzyme devoid of lipid (i.e., the apodehydrogenase or apoBDH) can be reactivated with soluble lecithin or by insertion into phospholipid vesicles containing lecithin. Two different models have been proposed to explain the sigmoidal lipid activation curves. For both models, activation of BDH is assumed to require the binding of two lecithin molecules per functional unit. Activation of soluble enzyme (dimeric form) by short-chain (soluble) lecithin is consistent with a model in which lecithin binding is noncooperative, whereas activation of the membrane-bound enzyme (tetrameric form) indicates cooperativity between the lecithin binding sites. A new comprehensive model is presented in which lecithin is considered to be an essential allosteric activator that shifts the equilibrium between conformational states of the enzyme. Resonance energy transfer data, reflecting NADH binding to membrane-bound and soluble apoBDH, are consistent with such a lecithin-induced conformational change. Apparent dissociation constants for binding of NADH to BDH are approximately 10 microM and approximately 37 microM for BDH activated by bilayer and soluble lecithin, respectively. The maximal fluorescence resonance energy transfer (delta F max) increases with higher mole fraction of lecithin in the bilayer. The largest changes occur between mole fractions 0 and 0.13, thereby correlating with enzymic function. Essentially no binding of NADH is observed in the absence of lecithin.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Monoclonal antibodies for structure-function studies of (R)-3-hydroxybutyrate dehydrogenase, a lipid-dependent membrane-bound enzyme.Biochem J. 1993 Jun 15;292 ( Pt 3)(Pt 3):863-72. doi: 10.1042/bj2920863. Biochem J. 1993. PMID: 7686368 Free PMC article.
-
Coenzyme binding by 3-hydroxybutyrate dehydrogenase, a lipid-requiring enzyme: lecithin acts as an allosteric modulator to enhance the affinity for coenzyme.Biochemistry. 1989 Jun 27;28(13):5354-66. doi: 10.1021/bi00439a007. Biochemistry. 1989. PMID: 2550053
-
Noncooperative vs. cooperative reactivation of D-beta-hydroxybutyrate dehydrogenase: multiple equilibria for lecithin binding are determined by the physical state (soluble vs. bilayer) and composition of the phospholipids.Biochemistry. 1987 Aug 25;26(17):5283-93. doi: 10.1021/bi00391a011. Biochemistry. 1987. PMID: 3676253
-
Phospholipid protection against proteolysis of D-beta-hydroxybutyrate dehydrogenase, a lecithin-requiring enzyme.J Biol Chem. 1985 Feb 10;260(3):1661-9. J Biol Chem. 1985. PMID: 3881438
-
Lipid-protein interactions in biomembranes studied through the phospholipid specificity of D-beta-hydroxybutyrate dehydrogenase.Biochimie. 1986 Mar;68(3):481-91. doi: 10.1016/s0300-9084(86)80015-3. Biochimie. 1986. PMID: 3091085 Review.
Cited by
-
Monoclonal antibodies for structure-function studies of (R)-3-hydroxybutyrate dehydrogenase, a lipid-dependent membrane-bound enzyme.Biochem J. 1993 Jun 15;292 ( Pt 3)(Pt 3):863-72. doi: 10.1042/bj2920863. Biochem J. 1993. PMID: 7686368 Free PMC article.
-
Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer.Biophys J. 2001 Jun;80(6):2536-45. doi: 10.1016/S0006-3495(01)76225-X. Biophys J. 2001. PMID: 11371432 Free PMC article.
-
Activity of the yeast Tat2p tryptophan permease is sensitive to the anti-tumor agent 4-phenylbutyrate.Curr Genet. 2004 Nov;46(5):256-68. doi: 10.1007/s00294-004-0531-7. Curr Genet. 2004. PMID: 15490173